Home health services are increasingly seen as a way to alleviate prescription abandonment and improve medication adherence.
Utilizing behavioral science to guide support interventions is critical to achieve the maximum efficacy and efficiency of patient engagement programs.
As the biopharma industry intensifies its approach to patient engagement, these proven results are becoming critical success factors.
With a healthy lifestyle such as weight-bearing exercise and proper nutrition along with appropriate medicines, many people can avoid or reduce the complications of osteoporosis.
A new generation of patient engagement programs is creating an integrated environment where human engagement, technology and data co-exist in symbiosis.
Many companies are now shifting focus to how AI can be leveraged in the commercial stage, specifically in patient engagement given its profound potential to impact the last mile of care delivery.
A new generation of patient engagement services like MY Journey™ are being utilized to create an integrated environment where human engagement, technology and data co-exist in harmony.
Review key findings and takeaways from a national survey of HCPs to better understand the opportunities HCPs believe exist for enhancing the support provided by life science companies to both their medical practices and their patients.
View our webinar to learn how life sciences companies are embracing AI. This type of patient engagement can make the difference between good and adverse health outcomes and patient satisfaction.
People with rare diseases face an uphill battle in so many ways, but there are key areas of support to turn to.
Watch this on-demand webcast with VMS CEO explaining how patient engagement can be a core part of your business strategy to drive a competitive advantage.
As biopharma shifts its outlook to the post-COVID era, there is an opportunity for the industry to transform how it delivers patient and HCP engagement.
COVID-19 has created a difficult environment for immunocompromised people due to many medications that treat rheumatic diseases.
This issue explores how patients have responded to the digital transformation and why 86% of tech professionals said the pharma digital moment has arrived.
In our July Patient Services Report, we provide an in-depth look at the recent rare disease market and evaluate the investment biopharma is making to enhance patient and HCP support in this space.
“Many people are familiar with the physical appearance of psoriasis, but most are unaware of the severe psychological impact it has on the patient,” says Clinical Nurse Educator Samara Ashley.
Certain pandemic driven trends will continue to persist, thus having lasting impacts on how we develop commercial strategies.
Alzheimer's disease is the number one illness faced by caregivers of patients over 65 according to the 2020 Caregiving in the U.S. study by the National Alliance for Caregiving.
We often attribute forgetfulness to growing older, but could it be a sign of a more serious condition? Alzheimer’s and dementia deaths increased by 16% during the COVID-19 pandemic.
Patient barriers and HCP challenges result in 84% of patients making errors in self-injecting and 45% of patients skipping and avoiding their injections altogether.
Several risk factors for osteoporosis are not within our control, but we do have some control of our bone health using nutrition tailored to our needs. Read Katie Driessens tips on our blog.
In our April Patient Services Report, we explain how to measure patient support programs to assess their impact on patient adherence.
As a nurse, you play many roles in healthcare, but one of the most lasting and impactful roles is that of a patient educator.
In the March Patient Services Report, we share insights on how clients are navigating this and recent technology and model innovations that have enabled success.
Tune in for a forward-leaning conversation about what the next frontier of patient support programs will look like as biopharma adopts new-to-market offerings.
Patient adherence has become a competitive driver for the life sciences industry to realize the full clinical potential of their therapies and achieve even greater commercial success.
As a Clinical Nurse Educator, Liza Maricle sees the negative impact of easy-to-obtain meals that are consumed out of convenience. Read Liza's tips for better nutrition.
The patient journey is rarely linear for those with a rare disease. Jill Doran shares how patients and families who receive education and support can typically manage it bettter.
In our February Patient Services Report, VMS explores why patient adherence has become a competitive driver and is no longer optional for biopharma to invest in.
VMS Clinical Nurse Educator Jessica Schulte shares a heart-warming story about her nephew Weston, born with a rare congenital heart defect. Jessica shares tips for caregivers who receive a devastating diagnosis.
The heart is an amazing machine. Each minute, this muscle pumps 1.5 gallons of blood through 60,000 miles of heart vessels!
VMS Clinical Nurse Educator Mary Schmalfeldt has tips for how HCPs can help their patients become an RA Warrior.
Here's what we believe are the most notable trends for 2021 and a few of our takeaways from the CEC and JP Morgan Healthcare conference this month
This National Pharmacist Day January 12, VMS BioMarketing extends a heartfelt thank you to the many pharmacists who work in our Clinical Educator networks.
During this National Alzheimer's Awareness Month, I've been reflecting on the many fond memories I have of my grandmother when I was a young child.
Presentation by VMS BioMarketing President and CEO Andrea Heslin Smiley at the CBI HUB, SPP and eServices Virtual Conference.
VMS Clinical Nurse Educators explain in this PM360 article how biopharma companies can support patient caregivers
VMS continually conducts primary and secondary research to identify the latest trends in the behavioral health space
One way healthcare professionals can explain to patients the correlation between diabetes and heart disease.
Measured Impact of VMS Self-injection Therapy Program on Target HCPs and Patients
Biopharma is addressing patient adherence during COVID-19, by leveraging predictive analytics and tech-enabled support models like OneVoiceTM
As an oncology nurse specializing in breast cancer, I have witnessed the struggles patients endure and offer these suggestions for healthcare professionals working with people newly diagnosed with breast cancer.
Read VMS CEO Andrea Heslin Smiley’s comments in this MM&M e-book
Measured Impact of VMS Self-injection Therapy Program on Target HCPs and Patients
Industry also can play a role in supporting patient transitions to ensure the safe use of prescribed products and therapy management
Read VMS SVP Abigail Mallon’s comments in this PharmaVOICE article
Results of a healthcare professional survey we conducted on behalf of our biopharma clients
An interview with VMS CEO Andrea Heslin Smiley in the American Nurses Foundation newsletter
Read VMS SVP Abigail Mallon’s comments in this PharmaVOICE article
PharmaVOICE article illustrates why VMS clinical educators are driven to help patients on a 1:1 basis to manage chronic illnesses
Across our Biopharma programs, numerous patient and HCP insights demonstrate the large and growing impact CNEs are having
Read VMS SVP Abigail Mallon’s comments in PM360 magazine
PM360 magazine selected the VMS Insight Incubator™ as one of the most innovative services in the biopharma industry in 2019
Measured Impact of VMS Biologic Therapy Program on Target HCPs and Patients
The pandemic remains a highly prevalent factor requiring biopharma to deploy innovative HCP and patient engagement for the new normal
Biopharma R&D innovation and the role of Clinical Nurse Educators
View this on-demand on the PharmaVOICE website
Market forces and pandemic-related trends are increasing biopharma’s need to focus on areas where Clinical Nurse Educators can drive impact
Risk of patient non-adherence is at an all-time high
Patients receiving health coaching were almost 4X as likely to be adherent to medications
VMS shares recent insights from our Clinical Educators
Patient adherence is at the forefront of the conversation and is becoming a top business priority for Biopharma this year.
Measured Impact of VMS Oncology Program on Target HCPs and Patients